Seqirus Logo (WIPO, 07/01/2015)
WIPOProtect this trademark from copycats!
With our trademark monitoring alerts, you are automatically notified by email about copycats and free riders.
The International trademark Seqirus was filed as Figurative mark on 07/01/2015 at the World Intellectual Property Organization.
Logodesign (Wiener Klassifikation)
#Lines, bands #Letters presenting a special form of writing #Colours #Curved lines or bands (except A 26.11.13) #Two predominant colours
| Trademark form | Figurative mark |
| File reference | 1271876 |
| Countries | 
|
| Base trademark |
No. 1701396,
June 18, 2015
|
| Application date | July 1, 2015 |
| Expiration date | July 1, 2025 |
Trademark owner
Point, 29 Market Street
Maidenhead, Berkshire SL6 8AA
GB
Maidenhead, Berkshire SL6 8AA
GB
Trademark representatives
Level 15,
1 Nicholson Street
AU
goods and services
01
Chemical and biological reagents in this class; cell
cultures and media in this class; chemical test kits for
scientific and laboratory use in this class; chemical
preparations for scientific and/or industrial purposes;
diagnostic and testing agents in this class; chemical and
biological reagents for non-medical purposes; chemical and
biological reagents for industrial use for anti-body
screening, blood grouping, and for the typing and detection
of specific blood cells, determining the presence of
antigens on blood cells, and the detection of relevant
complement compounds and immunoglobulin subtypes; chemical
test kits for the detection of specific blood cells,
determining the presence of antigens on blood cells, and the
detection of relevant complement compounds and
immunoglobulin subtypes for laboratory or research use;
chemical preparations for industrial use for anti-body
screening, blood grouping, and the typing and detection of
specific blood cells
05
Pharmaceutical preparations and substances in this class;
vaccines; blood products in this class; products derived
from blood and products derived from recombinant dna
technology; serums; antibodies; pharmaceutical test kits in
this class, being for diagnostic medical purposes; influenza
vaccines; adjuvants and antigens; pharmaceutical
preparations and substances for the treatment and/or
prevention of blood or bleeding disorders; blood products in
this class, namely, blood plasma, reagent blood cells;
products derived from blood and products derived from
recombinant dna technology, namely, immunoglobulins, human
albumin, blood clotting factors, plasma volume expanders,
blood proteins for therapeutic use; serums, namely,
anti-venoms; medicated serums for the treatment of blood or
bleeding disorders; test kits in the class, namely, invitro
diagnostic reagent test kits for use in detecting cell
mediated immune response; pharmaceutical preparations and
substances, namely, rhd reagents for the detection of
specific antigens or in blood typing; pharmaceutical
preparations, namely, reagent red blood cells used to detect
antibodies or igg subtypes; pharmaceutical preparations,
namely, monoclonal and polyclonal antibodies; pharmaceutical
preparations, namely, reagents for medical/clinical use for
the typing and detection of specific blood cells, and the
detection of relevant compliment components and
immunoglobulin subtypes
44
Medical services; medical information services; health care
services; health care information services; patient support
services in the nature of providing health care and medical
care information services, patient support programs and
patient assistance programs for providing low cost drugs;
providing medical information concerning blood products;
providing medical information concerning vaccines,
anti-venoms and immunohaematology products, namely,
diagnostic reagents; patient support services, namely,
providing medical information, including patient medical
information via an Internet-based database, where patients
can enquire about medical issues and procedures from other
patients and can relay information about their medical
experiences for support and community
Trademark history
| Date | Document number | Area | Entry |
|---|---|---|---|
| May 15, 2017 | 2017/20 Gaz | IN | Rejection |
| May 10, 2017 | 2017/19 Gaz | MX | Rejection |
| March 3, 2017 | 2018/39 Gaz | CN | Rejection |
| February 17, 2017 | 2017/17 Gaz | KR | RAW: Rule 18ter(2)(ii) GP following a provisional refusal |
| November 17, 2016 | 2017/2 Gaz | JP | RAW: Rule 18ter(2)(ii) GP following a provisional refusal |
| November 4, 2016 | 2017/23 Gaz | SG | RAW: Rule 18ter(2)(ii) GP following a provisional refusal |
| October 13, 2016 | 2016/43 Gaz | CH | Rejection |
| October 7, 2016 | 2016/41 Gaz | NO | RAW: Rule 18ter(2)(i) GP following a provisional refusal |
| September 8, 2016 | 2016/37 Gaz | EM | Rejection |
| July 7, 2016 | 2016/30 Gaz | JP | Rejection |
| May 27, 2016 | 2016/23 Gaz | KR | Rejection |
| April 28, 2016 | 2016/19 Gaz | NO | Rejection |
| April 27, 2016 | 2016/21 Gaz | SG | Rejection |
| October 28, 2015 | 2015/50 Gaz | AU | Correction |
| July 1, 2015 | 2015/43 Gaz | AU | Registration |
ID: 141271876